Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Molnupiravir did not reduce the frequency of COVID-19-associated hospitalisations
or death among high-risk vaccinated adults in the community.

Related Keywords

London ,City Of ,United Kingdom ,Nuffield ,Oxfordshire ,Midlands ,Leicestershire ,Northern Ireland ,Craigavon ,Scotland ,British ,Yusuf Soni ,Julianne Brown ,Mike Butler ,Olajide Popoola ,Greg Irving ,Divya Shah ,Afsana Safa ,James Kennard ,Sarit Ghosh ,Satash Sehdev ,Omair Razzaq ,Umar Khan ,Scot Richardson ,Ivor Singh ,Steve Granier ,Robin Fox ,Gerard Burns ,Devesh Dhasmana ,Shanna Goodman ,Patrick Moore ,Akosuaa Agyeman ,Damien Allcock ,Aleksandra Howell ,Joanna Yong ,Pete Wilson ,Tanveer Ahmed ,Adrian Beltran Martinez ,Henry Okeke ,Iqbal Hussain ,Alexander Pora ,Ishtiaq Gilkar ,Ruth Penfold ,Clairei Mackintosh ,Daniel Murphy ,David Lewis ,Mehul Mathukia ,Kavil Patel ,Laura Brennan ,Ridgeback Biotherapeutics ,Stacey Fisher ,Kyle Knox ,Jon Dickson ,Marie Imlach ,James Lunn ,Maximillian Nj Woodall ,Vibhore Prasad ,Seb Morton ,Serge Engamba ,Francis Yongblah ,Nicholas Jacobsen ,Christopher Krasucki ,Nick Wooding ,Oluseyee Benedict ,Azhar Zafar ,Aadil Sheikh ,Zelda Cheng ,Baljinders Sidhu ,Chinonso Ndukauba ,Olufunto Ogundapo ,Satveer Poonian ,Simon Hutchinson ,Michael Wong ,Nicola Lester ,Rishabh Prasad ,Ruth Danson ,Tamsin Sevenoaks ,David Wingfield ,Amit Patel ,Chris Thalasselis ,Glaxosmithkline ,United Kingdom Medical Research Council ,Dunhill Medical ,Funding Strategy Group ,Pfizer ,University College London Hospitals ,Research Unit ,Astrazeneca ,Department Of Health ,Research Professors Funding Committee ,Wellcome ,Research Scotland ,Nuffield Department Of Primary Care Health Sciences ,United Kingdom National Health Service ,Wellcome Trust Ph ,United Kingdom National Institute For Health ,University Of Oxford ,Care Research Wales ,Regulatory Agency ,Research Collaboration ,National Institute For Health ,Biomedical Research Centre ,Funding Committee ,Kathleen Harper Fund ,National Records Service Of Scotland ,Cardiff University ,Research Centre ,Community Healthcare Medtech ,Health Technology Assessment ,European Clinical Research Alliance On Infectious Diseases ,Research Collaboration Oxford ,British Society Of Antimicrobial Chemotherapy ,Bristol Myers Squibb ,Oxford University ,Care National Audit ,University Of Swansea ,British Society For Antimicrobial Chemotherapy ,Public Health Scotland ,Therapeutics Task ,Clinical Research Network ,Research United Kingdom ,Drugs For Neglected Diseases Initiative ,Care Research ,United Kingdom Based ,Kingdom National Institute ,Englj Med ,United Kingdom Medicines ,South Central Berkshire Research Ethics Committee ,Health Research Authority ,Practice Hubs ,Care Excellence ,Pharmacol Ther ,Res Methodol ,Nigel Bird ,Nigel De Kare Silver ,Steve Frost ,Richard Gaunt ,Tom Law ,Grem Lee ,Rhiannon Nally ,Simon Royal ,Vanessa Short ,Sharon Woods ,Nuffield Department ,Primary Care Health ,Social Care ,Health Technology Assessment General Committee ,United Kingdom National Institute ,British Society ,Blood Cancer United Kingdom ,Biotest United Kingdom ,Wellcome Trust ,Viiv Healthcare ,Transplant Research Unit ,Dunhill Medical Trust ,Antibiotic Research United Kingdom ,Abbott Diagnostics ,Technology Assessment General Funding Committee ,Healthcare Medtech ,In Vitro Diagnostics Co Operative ,Protection Research Unit ,Health Care Associated Infections ,In Vitro Diagnostics ,Wellcome Trust Phd ,European Clinical Research Alliance ,Infectious Diseases ,Neglected Diseases Initiative ,Skills Personal ,Research Network ,Thames Valley ,South Midlands ,Social Care Board ,Therapeutics Task Force ,Intensive Care National Audit ,National Records Service ,Secure Anonymised Information Linkage ,Social Care Northern ,